PEDIACARE CHILDREN'S ALLERGY OTC
Generic Name and Formulations:
Diphenhydramine HCl 12.5mg; per 5mL; liq; cherry-flavor, alcohol-free, contains sodium 14mg/5mL.
McNeil Consumer Healthcare
Indications for PEDIACARE CHILDREN'S ALLERGY:
Rhinorrhea, sneezing, allergy symptoms.
<4yrs: do not use. 4–5yrs: not recommended. 6–11yrs: 5mL every 4 hours; max 6 doses/24 hours.
Children <4yrs old. Concomitant other diphenhydramine products (including topicals). For use as a sedative hypnotic.
Glaucoma. GI or GU obstruction. Asthma. Lower respiratory disorders.
See Contraindications. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, excitability.
Liq—4oz (w. dosing cup)
Endocrinology Advisor Articles
- Testosterone Use Remains High Among Men With Coronary Artery Disease
- Higher Risk for Venous Thromboembolism With Oral vs Transdermal HRT
- Comparing Osteoporosis Screening, Treatment Strategies in Postmenopausal Women
- Primary Characteristics of PCOS Predictive of Obstetric Complications
- Free vs Total Serum 25(OH)D as Biomarkers for Bone Health in Older Women
- ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care
- Sleep Habits Affect Insulin Sensitivity in Adolescents With Overweight, Obesity
- Levothyroxine Associated With Increased Mortality in Patients With Heart Failure
- Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
- Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes
- Insulin Analogs vs Regular Human Insulin for Type 2 Diabetes
- Diabetic Ketoacidosis May Affect Brain Development in Children With T1D
- Higher Rates of Comorbidities Among Holocaust Survivors
- Population Health Data May Help Identify Patients at Risk for CVD
- Newborn Genomic Sequencing Can Identify Disease Risk